Dielwart, M.F.

patient treatment cancer prostate cancer toxicity trial prostate radiation tumor stage survival oncol finition analysis signi radiotherapy group study grade hyperthermia ht treatments result radiat failure ficant radiation oncology oncology control randomized table high-dose arm dose escalation signi ficantly tumor diameter astro outcome cervix high-dose signi ficant incidence netherland number therapy disease-speci fic survival month grade 2 difference carcinoma 78- gy arm gi toxicity 78 gy figo stage follow-up lymph chemotherapy backdating phoenix factor volume 0.000 gu toxicity diameter increase escalation figo stage iiib effect signi ficant improvement response characteristic cervix cancer tumour control lymph nodes univariate analysis 7 years 68 gy multivariate 5 years level treatment arms uterine cervix